Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants

Clinical trial NCT00831311 · COMPLETED

Trial details

NCT number: NCT00831311
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diphtheria Tetanus Pertussis Haemophilus Influenzae Type b Poliomyelitis

Start date: 2004-10-01
Primary completion: 2005-11-01
Enrollment: 624

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.